首页 | 本学科首页   官方微博 | 高级检索  
     


Efficacy and safety of lixisenatide in patients with type 2 diabetes and renal impairment
Authors:Markolf Hanefeld MD  Juan M. Arteaga MD  Lawrence A. Leiter MD  Giulio Marchesini MD  Elena Nikonova MD  Marina Shestakova PhD  William Stager PhD  Ricardo Gómez‐Huelgas MD
Affiliation:1. Centre for Clinical Studies, GWT‐Technical University Dresden, Dresden, Germany;2. National University of Colombia School of Medicine, Bogotá D.C., Colombia;3. Keenan Research Centre in the Li Ka Shing Knowledge Institute of St Michael's Hospital, University of Toronto, Toronto, Canada;4. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy;5. Artech Information Systems, LLC, Morristown, New Jersey;6. Endocrinology Research Center, Moscow, Russian Federation;7. I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation;8. Sanofi, Bridgewater, New Jersey;9. Internal Medicine Department, University Regional Hospital, Malaga, Spain;10. Malaga Institute of Biomedicine (IBIMA), Malaga, Spain;11. CIBER Fisiopatología Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain
Abstract:
Keywords:GLP‐1  incretin therapy  meta‐analysis  type 2 diabetes
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号